MARKET

QGEN

QGEN

Qiagen
NYSE
45.37
-0.33
-0.71%
Opening 14:24 05/20 EDT
OPEN
45.75
PREV CLOSE
45.69
HIGH
45.81
LOW
45.22
VOLUME
780.20K
TURNOVER
0
52 WEEK HIGH
49.18
52 WEEK LOW
34.77
MARKET CAP
10.06B
P/E (TTM)
29.73
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at QGEN last week (0513-0517)?
Weekly Report · 9h ago
QIAGEN's (QGEN) QCI Interpret Gets European IVDR Certification
NASDAQ · 5d ago
Qiagen Secures European IVDR Certification For QIAGEN Clinical Insight Interpret, Its Clinical Decision Support Software
QIAGEN announces updated version of its clinical decision support platform for molecular profiling of hereditary and somatic diseases. QIAGEN Clinical Insight Interpret for NGS molecular profiling has received a European Union certificate. The platform has received the European Union Technical Documentation Assessment and Quality Management System certificate.
Benzinga · 5d ago
QIAGEN (QGEN) Wins FDA Nod for QIAstat-Dx Respiratory Panel Plus
NASDAQ · 6d ago
QIAGEN gets FDA clearance for QIAstat-Dx Respiratory Panel Plus
Healthcare QIAGEN gets FDA clearance for QIAstat-Dx Respiratory Panel Plus to aid in the diagnosis of upper respiratory infections. Dutch medtech said the panel covers 21 viral and bacterial targets. QIAgen said it working to expand its offerings in the US.
Seeking Alpha · 05/13 18:06
QIAGEN (QGEN) to Enhance Forensics With New Partnership
NASDAQ · 05/13 16:22
Weekly Report: what happened at QGEN last week (0506-0510)?
Weekly Report · 05/13 09:24
FDA Clears Qiagen's QIAstat-Dx Respiratory Syndromic Testing Panel
NASDAQ · 05/13 06:45
More
About QGEN
Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.

Webull offers Qiagen NV stock information, including NYSE: QGEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, QGEN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading QGEN stock methods without spending real money on the virtual paper trading platform.